Boxer Capital, LLC - Q1 2015 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q1 2015
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC32Q3 202355.2%
BEIGENE LTD31Q3 202315.6%
KURA ONCOLOGY INC.24Q3 20214.7%
ROCKET PHARMACEUTICALS INC23Q3 20235.4%
DBV TECHNOLOGIES S A23Q3 20233.9%
MEI PHARMA INC21Q2 20231.4%
SYNDAX PHARMACEUTICALS INC20Q3 20213.1%
GOSSAMER BIO INC19Q3 20234.7%
ODONATE THERAPEUTICS INC18Q1 202212.5%
ESPERION THERAPEUTICS INC NE18Q2 202111.0%

View Boxer Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Boxer Capital, LLC Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
IDEAYA Biosciences, Inc.February 14, 20232,202,8124.6%
Milestone Pharmaceuticals Inc.February 14, 2023698,8612.0%
SpringWorks Therapeutics, Inc.September 19, 20223,421,5415.7%
iTeos Therapeutics, Inc.May 11, 20222,154,0586.1%
Atreca, Inc.February 14, 20222,202,3337.2%
Biomea Fusion, Inc.February 14, 20221,188,4054.1%
Cabaletta Bio, Inc.February 14, 2022540,0001.9%
CymaBay Therapeutics, Inc.February 14, 2022? ?
DBV Technologies S.A.February 14, 20221,067,2991.9%
Elevation Oncology, Inc.February 14, 2022872,7803.8%

View Boxer Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-22
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-12
42024-02-08
SC 13D/A2024-02-08
42024-01-25
SC 13D/A2024-01-25
SC 13G2024-01-18
SC 13D/A2023-12-18

View Boxer Capital, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Boxer Capital, LLC's holdings

CSVXLS